Form 4 for WGS GeneDx Holdings Corp.
Accepted 2024-07-31 00:00:00 ET · period of report 2024-07-29 · accession 0000950170-24-088679 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-07-31 | 2024-07-29 | WGS | OPKO HEALTH, INC. | 10% | S - Sale | $33.86 | -50.0K | 3.07M | -2% | -$1.69M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-07-29 | S | D | 50,000 | $33.86 | 3,073,403 | D | — | — | (F1) The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from 33.56 to $34.16, inclusive. The reporting person undertakes to provide to GeneDx Holding Corp. (the "Company"), any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4. |